A Prospective Study Investigating Prediagnostic Leukocyte Telomere Length and Risk of Developing Rheumatoid Arthritis in Women
- PMID: 26773113
- PMCID: PMC4738071
- DOI: 10.3899/jrheum.150184
A Prospective Study Investigating Prediagnostic Leukocyte Telomere Length and Risk of Developing Rheumatoid Arthritis in Women
Abstract
Objective: To prospectively examine the association between leukocyte telomere length (LTL) and subsequent rheumatoid arthritis (RA) development in women.
Methods: Using a case-control design nested within the prospective Nurses' Health Study (NHS), NHS II (NHSII), and Women's Health Study (WHS), each validated case of RA with a prediagnostic blood sample was matched to 3 controls by cohort, age, menopausal status, postmenopausal hormone therapy, and blood collection covariates. We measured telomere length in genomic DNA extracted from stored buffy coat samples using quantitative PCR. We used unconditional logistic regression to determine OR and 95% CI, and random-effects metaanalysis to combine study results.
Results: In total, we analyzed 296 incident RA cases and 827 matched controls. Mean age of diagnosis among women who developed RA was 60.5 in NHS/NHSII and 61.3 in WHS. Metaanalysis demonstrated that longer prediagnostic LTL was associated with increased RA risk when women in the longest versus shortest LTL tertile were compared (OR 1.51, 95% CI 1.03-2.23, Pheterogeneity = 0.27). However, statistically significant between-study heterogeneity was observed for the intermediate tertile category (Pheterogeneity = 0.008). We did not observe heterogeneity by menopausal status, inflammatory cytokine levels, age at diagnosis, age at blood collection, body mass index, seropositivity, or HLA-DRβ1 shared epitope status.
Conclusion: Our results do not support an involvement for short LTL preceding RA development.
Keywords: INCIDENT COHORT; LEUKOCYTES; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TELOMERE; WOMEN.
References
-
- Pincus T, Callahan LF. Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity. J Rheumatol. 1986;13:841–5. - PubMed
-
- Thewissen M, Stinissen P. New concepts on the pathogenesis of autoimmune diseases: a role for immune homeostasis, immunoregulation, and immunosenescence. Crit Rev Immunol. 2008;28:363–76. - PubMed
-
- Prelog M. Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev. 2006;5:136–9. - PubMed
-
- Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol. 2010;104:183–90. quiz 90–2, 210. - PubMed
-
- Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev. 2004;3:401–6. - PubMed
Publication types
MeSH terms
Grants and funding
- HL099355/HL/NHLBI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 CA67262/CA/NCI NIH HHS/United States
- R01 CA067262/CA/NCI NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- UM1 CA176726/CA/NCI NIH HHS/United States
- K24 AR066109/AR/NIAMS NIH HHS/United States
- R01 AR059073/AR/NIAMS NIH HHS/United States
- R01 CA49449/CA/NCI NIH HHS/United States
- U01 CA067262/CA/NCI NIH HHS/United States
- P60 AR047782/AR/NIAMS NIH HHS/United States
- K24 AR052403/AR/NIAMS NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- R01 AR049880/AR/NIAMS NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- HL080467/HL/NHLBI NIH HHS/United States
- R01 CA049449/CA/NCI NIH HHS/United States
- RC1 HL099355/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials